Department for Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Clinton Health Access Initiative, Inc. (CHAI), Global Malaria, Boston, Massachusetts, United States of America.
PLoS One. 2024 Jul 29;19(7):e0286718. doi: 10.1371/journal.pone.0286718. eCollection 2024.
Private medicine retailers (PMRs) such as pharmacies and drug stores account for a substantial share of treatment-seeking for fever and malaria, but there are widespread concerns about quality of care, including inadequate access to malaria rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs). This review synthesizes evidence on the effectiveness of interventions to improve malaria case management in PMRs in sub-Saharan Africa (PROSPERO #2021:CRD42021253564). We included quantitative studies evaluating interventions supporting RDT and/or ACT sales by PMR staff, with a historical or contemporaneous control group, and outcomes related to care received. We searched Medline Ovid, Embase Ovid, Global Health Ovid, Econlit Ovid and the Cochrane Library; unpublished studies were identified by contacting key informants. We conducted a narrative synthesis by intervention category. We included 41 papers, relating to 34 studies. There was strong evidence that small and large-scale ACT subsidy programmes (without RDTs) increased the market share of quality-assured ACT in PMRs, including among rural and poorer groups, with increases of over 30 percentage points in most settings. Interventions to introduce or enhance RDT use in PMRs led to RDT uptake among febrile clients of over two-thirds and dispensing according to RDT result of over three quarters, though some studies had much poorer results. Introducing Integrated Community Case Management (iCCM) was also effective in improving malaria case management. However, there were no eligible studies on RDT or iCCM implementation at large scale. There was limited evidence that PMR accreditation (without RDTs) increased ACT uptake. Key evidence gaps include evaluations of RDTs and iCCM at large scale, evaluations of interventions including use of digital technologies, and robust studies of accreditation and other broader PMR interventions.
私人医药零售商(PMRs),如药店和药房,在寻求发热和疟疾治疗方面占有相当大的份额,但人们普遍对医疗质量表示担忧,包括无法充分获得疟疾快速诊断检测(RDT)和青蒿素为基础的联合疗法(ACT)。本综述综合了关于在撒哈拉以南非洲的 PMRs 中改善疟疾病例管理的干预措施的有效性证据(PROSPERO #2021:CRD42021253564)。我们纳入了评估支持 PMR 工作人员销售 RDT 和/或 ACT 的干预措施的定量研究,这些研究具有历史或同期对照组,以及与所接受的护理相关的结果。我们在 Medline Ovid、Embase Ovid、Global Health Ovid、Econlit Ovid 和 Cochrane 图书馆中进行了检索,并通过联系关键知情人来确定未发表的研究。我们按干预类别进行了叙述性综合。我们共纳入了 41 篇论文,涉及 34 项研究。有强有力的证据表明,小规模和大规模的 ACT 补贴计划(不包括 RDT)增加了 PMRs 中质量保证的 ACT 的市场份额,包括在农村和较贫困群体中,在大多数情况下增加了 30 多个百分点。在 PMRs 中引入或加强 RDT 使用的干预措施导致发热患者接受 RDT 的比例超过三分之二,根据 RDT 结果配药的比例超过四分之三,尽管一些研究的结果要差得多。引入综合社区病例管理(iCCM)也能有效改善疟疾病例管理。然而,没有关于 RDT 或 iCCM 大规模实施的合格研究。有有限的证据表明 PMR 认证(不包括 RDT)增加了 ACT 的使用。关键的证据差距包括对 RDT 和 iCCM 的大规模评估、对包括使用数字技术的干预措施的评估,以及对认证和其他更广泛的 PMR 干预措施的可靠研究。